Liver Cell Structures and Cancer Risk

Nuclear envelope and predisposition to hepatic neoplasia

NIH-funded research Hackensack University Medical Center · NIH-11144524

This project explores how changes in the protective layer of liver cells might increase the risk of developing liver cancer, especially for those with chronic liver conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHackensack University Medical Center NIH-funded
Lab location1 site (Hackensack, United States)
Project IDNIH-11144524 on NIH RePORTER

What this research studies

Many people with long-term liver conditions, like nonalcoholic steatohepatitis, face a higher chance of developing liver cancer, but we don't fully understand the reasons behind this. This project focuses on the 'nuclear envelope,' a protective layer inside liver cells, and a specific protein called LAP1. Researchers believe that changes in LAP1, such as a switch in its form, could make liver cells more vulnerable to developing cancer. By uncovering these fundamental mechanisms, we aim to better understand why liver cancer develops and potentially discover new ways to prevent or treat it.

Who could benefit from this research

Good fit: This foundational research does not currently involve direct patient participation.

Not a fit: Patients not at risk for or diagnosed with hepatocellular carcinoma would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to new ways to identify individuals at high risk for liver cancer or develop new strategies for prevention and treatment.

How similar studies have performed: This project builds on the researchers' own preliminary findings regarding the LAP1 protein's role in liver cell changes, suggesting a novel approach to understanding liver cancer development.

Where this research is happening

Hackensack, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Causing AgentsCancer GenesCancer-Promoting GeneCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.